myNEO
Business Services · Belgium · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ottergemsesteenweg Zuid B300 Ghelamco Ar...Phone Number
+32 494499999Website
www.myneo.meRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About myNEO
myNEO is a biotechnology company specializing in immune-driven discovery through its ImmunoEngine platform, which focuses on neoantigen discovery, epitope prediction, and personalized cancer immunotherapy. The company provides AI-driven technologies and solutions for vaccine developers, biologics innovators, and pharmaceutical partners, enabling the development of safer and more effective immune-based therapies. Their offerings include personalized neoantigen discovery, construct design, and various target discovery services tailored for different therapeutic modalities. With a commitment to innovating immunotherapies, myNEO aims to transform the future of cancer treatment and immunotherapy.Explore more
Popular SearchesmyNEOSIC Code 87,873NAICS Code 54,541Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is myNEO your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at myNEO
Click to see if myNEO had a recent Job posting/layoffs
Check if myNEO has recently received funding, and reach out quickly before it becomes old news!
Check out if myNEO is spiking on competitors!
Product Launch: Get notified when myNEO launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
myNEO, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once myNEO has new funding data
Earning: See what the market has to say on myNEO recently announced quarterly report
Recommended Actions
Find VP level buyers at myNEO
Find 3 more new buyers
Company Profile Activity
Activity Insights
myNEO is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
myNEO is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about myNEO.
myNEO Tech Stack
A closer look at the technologies used by myNEO
myNEO News & Media
myNEO evolves into myNEO Therapeutics to reflect its new strategy to develop off-the-shelf cancer vaccine immunotherapeutics
GHENT, Belgium – October 25th 2023. myNEO, a biotech company focused on exploiting “dark genome” targets to develop novel therapeutic cancer vaccines, today announces its new name – myNEO Therapeutics. The new name reflects the company's transition from an immunogenomic profiling expert towards an integrated drug discovery company focused on the development of a pipeline of therapeutic cancer vaccines.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding myNEO
Sign Up For FreeTo access detailed company insights
myNEO is a biotechnology company specializing in immune-driven discovery through its ImmunoEngine platform, which focuses on neoantigen discovery, epitope prediction, and personalized cancer immunotherapy. The company provides AI-driven technologies and solutions for vaccine developers, biologics innovators, and pharmaceutical partners, enabling th... Read More
